Matches in DBpedia 2016-04 for { ?s ?p "Richard D. Nanula was appointed chief financial officer of Amgen Inc. (biotechnology) in August 2001 and served as executive vice president starting May 2001. He resigned in 2007 amid an SEC inquiry as to why company executives did not immediately disclose negative findings from drug trials. Nanula has also worked with Boeing and Miramax."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- Richard_Nanula abstract "Richard D. Nanula was appointed chief financial officer of Amgen Inc. (biotechnology) in August 2001 and served as executive vice president starting May 2001. He resigned in 2007 amid an SEC inquiry as to why company executives did not immediately disclose negative findings from drug trials. Nanula has also worked with Boeing and Miramax.".
- Q7328002 abstract "Richard D. Nanula was appointed chief financial officer of Amgen Inc. (biotechnology) in August 2001 and served as executive vice president starting May 2001. He resigned in 2007 amid an SEC inquiry as to why company executives did not immediately disclose negative findings from drug trials. Nanula has also worked with Boeing and Miramax.".
- Richard_Nanula comment "Richard D. Nanula was appointed chief financial officer of Amgen Inc. (biotechnology) in August 2001 and served as executive vice president starting May 2001. He resigned in 2007 amid an SEC inquiry as to why company executives did not immediately disclose negative findings from drug trials. Nanula has also worked with Boeing and Miramax.".
- Q7328002 comment "Richard D. Nanula was appointed chief financial officer of Amgen Inc. (biotechnology) in August 2001 and served as executive vice president starting May 2001. He resigned in 2007 amid an SEC inquiry as to why company executives did not immediately disclose negative findings from drug trials. Nanula has also worked with Boeing and Miramax.".